Adma Biologics Stock Technical Analysis
| ADMA Stock | USD 16.58 0.20 1.22% |
As of the 4th of March, ADMA Biologics shows the Risk Adjusted Performance of (0.06), coefficient of variation of (1,128), and Mean Deviation of 1.88. ADMA Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
ADMA Biologics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ADMA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ADMAADMA Biologics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.ADMA Biologics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 25.67 | Strong Buy | 3 | Odds |
Most ADMA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ADMA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ADMA Biologics, talking to its executives and customers, or listening to ADMA conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ADMA Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.53) | Earnings Share 0.86 | Revenue Per Share | Quarterly Revenue Growth 0.184 | Return On Assets |
ADMA Biologics's market price often diverges from its book value, the accounting figure shown on ADMA's balance sheet. Smart investors calculate ADMA Biologics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ADMA Biologics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that ADMA Biologics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ADMA Biologics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ADMA Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ADMA Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ADMA Biologics.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in ADMA Biologics on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding ADMA Biologics or generate 0.0% return on investment in ADMA Biologics over 90 days. ADMA Biologics is related to or competes with ACADIA Pharmaceuticals, Praxis Precision, Belite Bio, Ligand Pharmaceuticals, Soleno Therapeutics, Mirum Pharmaceuticals, and Dyne Therapeutics. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-... More
ADMA Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ADMA Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ADMA Biologics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 10.04 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 3.28 |
ADMA Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ADMA Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ADMA Biologics' standard deviation. In reality, there are many statistical measures that can use ADMA Biologics historical prices to predict the future ADMA Biologics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.58) |
ADMA Biologics March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.57) | |||
| Mean Deviation | 1.88 | |||
| Coefficient Of Variation | (1,128) | |||
| Standard Deviation | 2.4 | |||
| Variance | 5.76 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.58) | |||
| Maximum Drawdown | 10.04 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 3.28 | |||
| Skewness | 0.0404 | |||
| Kurtosis | 0.0926 |
ADMA Biologics Backtested Returns
ADMA Biologics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of return volatility over the last 3 months. ADMA Biologics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ADMA Biologics' Mean Deviation of 1.88, risk adjusted performance of (0.06), and Coefficient Of Variation of (1,128) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.39, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ADMA Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding ADMA Biologics is expected to be smaller as well. At this point, ADMA Biologics has a negative expected return of -0.31%. Please make sure to confirm ADMA Biologics' potential upside, daily balance of power, and the relationship between the maximum drawdown and kurtosis , to decide if ADMA Biologics performance from the past will be repeated in the future.
Auto-correlation | 0.51 |
Modest predictability
ADMA Biologics has modest predictability. Overlapping area represents the amount of predictability between ADMA Biologics time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ADMA Biologics price movement. The serial correlation of 0.51 indicates that about 51.0% of current ADMA Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.4 |
ADMA Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ADMA Biologics Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for ADMA Biologics across different markets.
About ADMA Biologics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ADMA Biologics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ADMA Biologics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ADMA Biologics price pattern first instead of the macroeconomic environment surrounding ADMA Biologics. By analyzing ADMA Biologics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ADMA Biologics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ADMA Biologics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0781 | 0.0694 | Price To Sales Ratio | 8.52 | 11.17 |
ADMA Biologics March 4, 2026 Technical Indicators
Most technical analysis of ADMA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ADMA from various momentum indicators to cycle indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.57) | |||
| Mean Deviation | 1.88 | |||
| Coefficient Of Variation | (1,128) | |||
| Standard Deviation | 2.4 | |||
| Variance | 5.76 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.58) | |||
| Maximum Drawdown | 10.04 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 3.28 | |||
| Skewness | 0.0404 | |||
| Kurtosis | 0.0926 |
ADMA Biologics March 4, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ADMA stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.01 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 16.48 | ||
| Day Typical Price | 16.51 | ||
| Price Action Indicator | 0.20 | ||
| Market Facilitation Index | 0.20 |
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |